---
title: "CStone files HKEX next-day disclosure return on share repurchase for cancellation"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/290709656.md"
description: "CStone Pharmaceuticals filed a next-day disclosure return with the HKEX regarding a share repurchase for cancellation. On June 24, the company bought back 500,000 shares at prices ranging from HKD 4.75 to HKD 4.84 per share, totaling an aggregate consideration of HKD 2,398,800. The issued share count remained unchanged at 1,600,749,183 as the repurchased shares had not yet been cancelled."
datetime: "2026-06-24T14:30:48.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/290709656.md)
  - [en](https://longbridge.com/en/news/290709656.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/290709656.md)
generator: "portal-rs"
---

# CStone files HKEX next-day disclosure return on share repurchase for cancellation

-   CStone Pharmaceuticals disclosed a 500,000-share buyback on June 24 for cancellation, priced HKD 4.75 to HKD 4.84 per share. \* Aggregate consideration was HKD 2,398,800; issued shares stayed at 1,600,749,183 because the repurchased shares were not yet cancelled. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. CStone Pharmaceuticals published the original content used to generate this news brief via IIS, the regulatory disclosure system operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20260624-12214009), on June 24, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT)

### Related Stocks

- [02616.HK](https://longbridge.com/en/quote/02616.HK.md)
- [00388.HK](https://longbridge.com/en/quote/00388.HK.md)
- [80388.HK](https://longbridge.com/en/quote/80388.HK.md)
- [HKXCY.US](https://longbridge.com/en/quote/HKXCY.US.md)

## Related News & Research

- [CStone plans first wave of global Phase III trials for CS2009 by end-2026](https://longbridge.com/en/news/297516705.md)
- [CStone Pharmaceuticals shareholders pass AGM resolutions](https://longbridge.com/en/news/290616544.md)
- [YSB Inc. files HKEX next-day disclosure return, reports share repurchase for cancellation](https://longbridge.com/en/news/298583165.md)
- [Rockwool updates bylaws after converting 451,329 A shares into B shares](https://longbridge.com/en/news/298556478.md)
- [China Brilliant Global proposes 1-for-10 share consolidation for shareholder vote at EGM](https://longbridge.com/en/news/298743567.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**